Puma Biotechnology, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
PBYI on Nasdaq
Location
10880 Wilshire Blvd., Suite 2150, Los Angeles, California

Insiders trading volume in the past year

Puma Biotechnology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alan H. Auerbach President and CEO, Director, 10%+ Owner $26.1M -$329K -1.24% Jul 17, 2024
Alvin F. Wong Chief Scientific Officer $634K -$35.7K -5.34% Feb 12, 2024
Maximo F. Nougues Chief Financial Officer $602K -$103K -14.6% Jul 17, 2024
Douglas M. Hunt The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. $493K -$65.2K -11.7% Jul 17, 2024
Jeffrey Jerome Ludwig Chief Commercial Officer $438K -$87.5K -16.6% Jul 17, 2024
Brian M. Stuglik Director $253K -$33.5K -11.7% Jun 18, 2024
Allison Dorval Director $200K -$37.1K -15.7% Jun 18, 2024
Ann C. Miller Director $183K Jun 15, 2021
Alessandra Cesano Director $180K Jun 18, 2024
Michael Patrick Miller Director $164K -$152K -48.2% Aug 12, 2024
Jay M. Moyes Director $161K -$73.5K -31.3% Jun 18, 2024
Troy E. Wilson Director $92.9K -$89.9K -49.2% Jun 18, 2024
Adrian Senderowicz Director $89.9K -$89.8K -50% Jun 18, 2024

Recent Insider Transactions by Companies or Individuals for Puma Biotechnology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.